Growth Metrics

Sanofi (SNY) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $16.6 billion.

  • Sanofi's Non-Current Debt rose 3164.33% to $16.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.6 billion, marking a year-over-year increase of 3164.33%. This contributed to the annual value of $16.1 billion for FY2025, which is 2617.06% up from last year.
  • According to the latest figures from Q4 2025, Sanofi's Non-Current Debt is $16.6 billion, which was up 3164.33% from $14.9 billion recorded in Q2 2025.
  • Over the past 5 years, Sanofi's Non-Current Debt peaked at $21.6 billion during Q2 2021, and registered a low of $12.6 billion during Q4 2024.
  • For the 5-year period, Sanofi's Non-Current Debt averaged around $16.2 billion, with its median value being $15.5 billion (2023).
  • As far as peak fluctuations go, Sanofi's Non-Current Debt tumbled by 2261.77% in 2022, and later surged by 3164.33% in 2025.
  • Over the past 5 years, Sanofi's Non-Current Debt (Quarter) stood at $19.6 billion in 2021, then decreased by 22.62% to $15.2 billion in 2022, then increased by 1.84% to $15.4 billion in 2023, then fell by 18.38% to $12.6 billion in 2024, then surged by 31.64% to $16.6 billion in 2025.
  • Its Non-Current Debt stands at $16.6 billion for Q4 2025, versus $14.9 billion for Q2 2025 and $12.6 billion for Q4 2024.